Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry May

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 22, 2019
Treatment as prevention enrolling at least 75% of individuals on ART will be needed to significantly reduce HIV prevalence in a HIV cohortHélène Jeulin, Eliette Jeanmaire, John M Murray, et al.
Journal of Hepatology|February 24, 2009
Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 studyDominique Salmon-Ceron, Eric Rosenthal, Charlotte Lewden, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2002
Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patientsGeneviève Chêne, Emmanuelle Angelini, Laurent Cotte, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 21, 2017
The variability of hepatitis B envelope is associated with HBs antigen persistence in either chronic or acute HBV genotype A infectionMarine Eschlimann, Brice Malvé, Aurélie Velay, et al.
The Journal of Antimicrobial Chemotherapy|June 30, 2011
Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trialSébastien Gallien, Joséphine Braun, Constance Delaugerre, et al.
AIDS (London, England)|June 6, 2014
Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000Philippe Morlat, Caroline Roussillon, Sandrine Henard, et al.
Plos One|June 18, 2015
Cancer-Related Causes of Death among HIV-Infected Patients in France in 2010: Evolution since 2000Marie-Anne Vandenhende, Caroline Roussillon, Sandrine Henard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2007
Urolithiasis in HIV-positive patients treated with atazanavirCarine Couzigou, Michel Daudon, Jean Luc Meynard, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2015
Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trialOlivier Lortholary, Caroline Roussillon, Céline Boucherie, et al.
Plos One|September 22, 2018
Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patientsClotilde Allavena, Matthieu Hanf, David Rey, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 22, 2019
Treatment as prevention enrolling at least 75% of individuals on ART will be needed to significantly reduce HIV prevalence in a HIV cohortHélène Jeulin, Eliette Jeanmaire, John M Murray, et al.
Journal of Hepatology|February 24, 2009
Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 studyDominique Salmon-Ceron, Eric Rosenthal, Charlotte Lewden, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2002
Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patientsGeneviève Chêne, Emmanuelle Angelini, Laurent Cotte, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 21, 2017
The variability of hepatitis B envelope is associated with HBs antigen persistence in either chronic or acute HBV genotype A infectionMarine Eschlimann, Brice Malvé, Aurélie Velay, et al.
The Journal of Antimicrobial Chemotherapy|June 30, 2011
Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trialSébastien Gallien, Joséphine Braun, Constance Delaugerre, et al.
AIDS (London, England)|June 6, 2014
Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000Philippe Morlat, Caroline Roussillon, Sandrine Henard, et al.
Plos One|June 18, 2015
Cancer-Related Causes of Death among HIV-Infected Patients in France in 2010: Evolution since 2000Marie-Anne Vandenhende, Caroline Roussillon, Sandrine Henard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2007
Urolithiasis in HIV-positive patients treated with atazanavirCarine Couzigou, Michel Daudon, Jean Luc Meynard, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2015
Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trialOlivier Lortholary, Caroline Roussillon, Céline Boucherie, et al.
Plos One|September 22, 2018
Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patientsClotilde Allavena, Matthieu Hanf, David Rey, et al.
Pageof 6